About MediBeacon
MediBeacon is a company based in St. Louis (United States) founded in 2011 by Richard Dorshow and Steve Hanley.. MediBeacon has raised $110.71 million across 12 funding rounds from investors including HHS, Huadong Medicine and St Louis City Health Dept. MediBeacon has completed 1 acquisition, including Mannheim Pharma & Diagnostics. MediBeacon operates in a competitive market with competitors including Physidia, Utopic Tech, FAST BioMedical, Accunea and Uro Bionics, among others.
- Headquarter St. Louis, United States
- Founders Richard Dorshow, Steve Hanley
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$110.71 M (USD)
in 12 rounds
-
Latest Funding Round
$16.09 M (USD), Series D
Aug 31, 2023
-
Investors
HHS
& 6 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of MediBeacon
MediBeacon has successfully raised a total of $110.71M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $16.09 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series D — $16.1M
-
First Round
First Round
(22 Aug 2013)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series D - MediBeacon | Valuation |
investors |
|
| Nov, 2022 | Amount | Series C - MediBeacon | Valuation | Huadong Medicine |
|
| Jan, 2022 | Amount | Series C - MediBeacon | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MediBeacon
MediBeacon has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Huadong Medicine and St Louis City Health Dept. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies focused VC firm operating across Missouri
|
Founded Year | Domain | Location | |
|
Private equity firm focused on acquisitions
|
Founded Year | Domain | Location | |
|
Venture capital and acceleration are provided to life science startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MediBeacon
MediBeacon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Mannheim Pharma & Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of diagnostic solutions for gastrointestinal microbial assessment and measurement
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MediBeacon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medibeacon Comparisons
Competitors of MediBeacon
MediBeacon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Physidia, Utopic Tech, FAST BioMedical, Accunea and Uro Bionics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of a hemodialysis monitoring device
|
|
| domain | founded_year | HQ Location |
Medical device for kidney diagnosis and management is developed.
|
|
| domain | founded_year | HQ Location |
Develops fluorescent in-vivo markers for measuring plasma volume and mGFR.
|
|
| domain | founded_year | HQ Location |
Monitoring devices for kidney function are developed by Accunea.
|
|
| domain | founded_year | HQ Location |
Develops innovative devices for bladder monitoring in urology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Medibeacon
Frequently Asked Questions about MediBeacon
When was MediBeacon founded?
MediBeacon was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is MediBeacon located?
MediBeacon is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Who is the current CEO of MediBeacon?
Steve Hanley is the current CEO of MediBeacon. They have also founded this company.
Is MediBeacon a funded company?
MediBeacon is a funded company, having raised a total of $110.71M across 12 funding rounds to date. The company's 1st funding round was a Series C of $8.13M, raised on Aug 22, 2013.
What does MediBeacon do?
MediBeacon is an optical diagnostic company that focuses on providing clinicians with critical patient information. MediBeacon creates light-activated agents, for non-invasive real-time kidney function monitoring system is in human clinical trials. Optical Renal Function Monitor (ORFM) is companys first product platform. This system is focused on real-time monitoring of kidney function. The company claims to hold multiple patents on its light-activated agents and has products for Nephrology and Gastroenterology in pipeline as on Dec15. Real-time point-of-care measurement of renal function is used to improve patient outcomes in the ICU and the operating suite and to achieve optimal dosing strategies for nephrotoxic drug interventions such as chemotherapeutics and imaging contrast agents.
Who are the top competitors of MediBeacon?
MediBeacon's top competitors include Physidia, Utopic Tech and Prantae Solutions.
How many acquisitions has MediBeacon made?
MediBeacon has made 1 acquisition, including Mannheim Pharma & Diagnostics.
Who are MediBeacon's investors?
MediBeacon has 7 investors. Key investors include HHS, Huadong Medicine, St Louis City Health Dept, Helix Investments, and HC2 Holdings.